NCT03006848 2026-02-23A Phase II Trial of Avelumab in Patients With Recurrent or Progressive OsteosarcomaSt. Jude Children's Research HospitalPhase 2 Completed19 enrolled 11 charts
NCT03074318 2022-04-29Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by SurgeryFred Hutchinson Cancer CenterPhase 1/2 Terminated35 enrolled 21 charts